These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 4384429)
1. The pharmacologic absis for the control of motion sickness by drugs. Brand J Pharmacol Physicians; 1968 Mar; 2(3):1-5. PubMed ID: 4384429 [No Abstract] [Full Text] [Related]
3. Further experiments on the prevention of motion sickness. GLASER EM; HERVEY GR Lancet; 1952 Mar; 1(6706):490-2. PubMed ID: 14898786 [No Abstract] [Full Text] [Related]
4. Control of simulator sickness in an AH-64 aviator. Kroll JD Aviat Space Environ Med; 1989 Dec; 60(12):1202-3. PubMed ID: 2604677 [TBL] [Abstract][Full Text] [Related]
5. A comparison of motion sickness remedies in severe sea conditions. Gahlinger PM Wilderness Environ Med; 2000; 11(2):136-7. PubMed ID: 10921365 [No Abstract] [Full Text] [Related]
6. Motion illness. Hervey GR Trans Med Soc Lond; 1984-1985; 101():14-20. PubMed ID: 6152833 [No Abstract] [Full Text] [Related]
7. Theory of antimotion sickness drug mechanisms. Wood CD; Graybiel A Aerosp Med; 1972 Mar; 43(3):249-52. PubMed ID: 4402925 [No Abstract] [Full Text] [Related]
8. Preventing motion sickness. Hodgson T Can Med Assoc J; 1982 Jun; 126(12):1374. PubMed ID: 7083089 [No Abstract] [Full Text] [Related]
9. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea. Noy S; Shapira S; Zilbiger A; Ribak J Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687 [TBL] [Abstract][Full Text] [Related]
10. Transderm scopolamine efficacy related to time of application prior to the onset of motion. Levy GD; Rapaport MH Aviat Space Environ Med; 1985 Jun; 56(6):591-3. PubMed ID: 4015572 [TBL] [Abstract][Full Text] [Related]
11. The prevention of seasickness with hyoscine, benadryl, and phenergan. GLASER EM; HERVEY GR Lancet; 1951 Oct; 2(6687):749-53. PubMed ID: 14874498 [No Abstract] [Full Text] [Related]
12. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy. Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736 [TBL] [Abstract][Full Text] [Related]
14. I heard that the adhesive patch you can wear to prevent motion sickness is available again. Why was it taken off the market? Mayo Clin Health Lett; 1998 Mar; 16(3):8. PubMed ID: 9516375 [No Abstract] [Full Text] [Related]
15. Neural mechanisms of motion sickness. Takeda N; Morita M; Horii A; Nishiike S; Kitahara T; Uno A J Med Invest; 2001 Feb; 48(1-2):44-59. PubMed ID: 11286016 [TBL] [Abstract][Full Text] [Related]
16. The effects of scopolamine and cyclizine on visual-vestibular interaction in humans. Gowans J; Matheson A; Darlington CL; Smith PF J Vestib Res; 2000; 10(2):87-92. PubMed ID: 10939683 [TBL] [Abstract][Full Text] [Related]
17. [Motion sickness: a disease caused by transportation]. Papatheodossiu N Z Krankenpfl; 1978 Jul; 71(7):290. PubMed ID: 27910 [No Abstract] [Full Text] [Related]